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Deletion of Wntless in myeloid cells
exacerbates liver fibrosis and the ductular
reaction in chronic liver injury
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Abstract
Background: Macrophages play critical roles in liver regeneration, fibrosis development and resolution. They are
among the first responders to liver injury and are implicated in orchestrating the fibrogenic response via multiple
mechanisms. Macrophages are also intimately associated with the activated hepatic progenitor cell (HPC) niche or
ductular reaction that develops in parallel with fibrosis. Among the many macrophage-derived mediators implicated in
liver disease progression, a key role for macrophage-derived Wnt proteins in driving pro-regenerative HPC activation
towards a hepatocellular fate has been suggested. Wnt proteins, in general, however, have been associated with both
pro- and anti-fibrogenic activities in the liver and other organs. We investigated the role of macrophage-derived Wnt
proteins in fibrogenesis and HPC activation in murine models of chronic liver disease by conditionally deleting Wntless
expression, which encodes a chaperone essential for Wnt protein secretion, in LysM-Cre-expressing myeloid cells
(LysM-Wls mice).
Results: Fibrosis and HPC activation were exacerbated in LysM-Wls mice compared to littermate controls, in the
absence of an apparent increase in myofibroblast activation or interstitial collagen mRNA expression, in both the TAA
and CDE models of chronic liver disease. Increased Epcam mRNA levels paralleled the increased HPC activation and
more mature ductular reactions, in LysM-Wls mice. Increased Epcam expression in LysM-Wls HPC was also observed,
consistent with a more cholangiocytic phenotype. No differences in the mRNA expression levels of key pro-inflammatory
and pro-fibrotic cytokines or the macrophage-derived HPC mitogen, Tweak, were observed. LysM-Wls mice exhibited
increased expression of Timp1, encoding the key Mmp inhibitor Timp1 that blocks interstitial collagen degradation, and,
in the TAA model, reduced expression of the anti-fibrotic matrix metalloproteinases, Mmp12 and Mmp13, suggesting a
role for macrophage-derived Wnt proteins in restraining fibrogenesis during ongoing liver injury.
Conclusion: In summary, these data suggest that macrophage-derived Wnt proteins possess anti-fibrogenic potential in
chronic liver disease, which may be able to be manipulated for therapeutic benefit.
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Background
Regardless of their aetiology, chronic liver diseases (CLDs)
share a common pathological mechanism, liver-injury stim-
ulated fibrosis, which, if progressive, can lead to cirrhosis,
liver failure, and cancer. The inflammatory response to
chronic injury, mediated by multiple parenchymal and
non-parenchymal cells, plays critical roles in fibrogen-
esis. Like inflammation, fibrosis is an adaptive response
to liver injury that, when appropriately regulated, facil-
itates tissue repair. How these protective responses be-
come maladaptive and the interplay between fibrogenesis
and repair, in the context of chronic injury and inflamma-
tion, is not well understood. Clinical observations and ex-
perimental models suggest that liver fibrosis is a dynamic,
bidirectional process with the capacity for recovery even
at advanced stages [1]. With no therapies available to pre-
vent or treat liver fibrosis, better understanding of the
mechanisms of fibrosis and repair and the role of inflam-
matory cells and mediators is crucial to developing new
therapeutic approaches.
In a healthy liver, injured parenchymal cells can be re-
generated through division of mature epithelial cells (hepa-
tocytes and bile duct-forming cholangiocytes). Following
severe or chronic injury, hepatocyte regeneration is im-
paired and an alternative regenerative pathway invol-
ving hepatic progenitor cells (HPCs) can be activated,
which is associated with the development of ductular
reactions (DRs) and progressive fibrosis, both in humans
and mouse models of CLD [2–4]. HPCs are thought to be
bipotential, capable of proliferation and differentiation into
hepatocytes, to replace injured cells or along the ‘ductular’
cholangiocyte lineage. Although capable of differentiation
into hepatocytes and cholangiocytes under clonogenic con-
ditions in vitro, the extent to which HPCs directly replace
epithelial cells to regenerate the liver is controversial [5–7].
The contribution of HPCs to liver regeneration in mouse
models likely depends on the extent to which epithelial
self-renewal is impaired. Indeed, it was recently demon-
strated that HPC activation in the setting of near total
hepatocyte death or senescence was necessary for sur-
vival [7]. DRs correlate with the extent of liver fibrosis
and may be postulated to represent a failed attempt to
regenerate the liver, but the causal relationship between
DRs and fibrosis remains to be established. HPCs are
intimately associated with fibrogenic activity, however,
as they exist in a niche composed of myofibroblasts, mac-
rophages and other leukocytes and extracellular matrix
components. Both cellular and matrix components of the
niche shape HPC activation and fate, and HPCs, in turn,
influence myofibroblasts and inflammatory cells.
Macrophages play critical roles in liver regeneration,
fibrosis development and resolution and are prominent
features of the fibrotic scar and DR niche [8–11]. Mac-
rophages have been shown to play a dichotomous role in
the context of liver fibrosis, as they play a pro-fibrogenic
role during the development of fibrosis whereas macro-
phage expression of matrix metalloproteinases and pro-
angiogenic factors crucially contributes to the resolution
of fibrosis during recovery from liver injury [10, 12] and
potentially even during ongoing injury [13]. Macrophage-
derived factors, including Wnt proteins, are also directly
implicated in controlling HPC proliferation, differentiation
and invasion into the parenchyma [14–16]. Macrophage
ablation reduced DR proliferation and expansion in sev-
eral models of CLD [10, 16] and, strikingly, injection of
macrophages caused transient TWEAK-dependent HPC
activation in healthy mice [15].
HPC activation during injury appears to recapitulate
liver epithelial cell development from hepatoblasts dur-
ing embryogenesis and involves reactivation of develop-
mental cell signalling pathways, including Wnt, Notch and
Hedgehog [17]. Wnt signalling drives hepatocellular differ-
entiation during development [18], and a similar function
for Wnt proteins (‘Wnts’) during chronic liver injury has
been suggested [14]. In contrast, macrophage-derived
Wnt7b was recently shown to drive cholangiocarcinoma
growth [19], highlighting the complex role of Wnt signalling
in chronic liver disease. Inflammatory cytokines (e.g. IL-6,
TNF, LTβ, IFNγ) [20–23], injury-induced growth factors
(e.g. TWEAK [24]) and extracellular matrix components
(e.g. collagen, laminin and fibronectin [25, 26]) are also im-
plicated in regulating HPC proliferation and fate.
Wnts comprise a family of 19 secreted glycoproteins
that activate target cells via β-catenin and β-catenin-
independent pathways to regulate cell proliferation,
differentiation and migration during development and
homeostasis, including in multiple adult stem cell niches
[18]. The pleiotropic targets and biological effects of Wnt
signalling in the liver are not well understood. A loss-of-
function mutation in the LRP6 gene, encoding a Wnt co-
receptor, was recently associated with human non-
alcoholic fatty liver disease [27]. Introduction of this mu-
tation in mice caused steatohepatitis via a β-catenin-
independent pathway, which was rescued by therapeutic
administration of Wnt3a [27]. β-catenin signalling is impli-
cated in liver repair and fibrogenesis, but the extent to
which this is Wnt-dependent is not clear, as β-catenin sta-
bilisation also occurs downstream of non-Wnt growth fac-
tors, such as hepatocyte growth factor [28]. In patients
and mice with acute liver failure, β-catenin activation
correlated with increased liver regeneration and (in pa-
tients) precluded the need for transplantation [29].
Multiple studies in rodent models of CLD have also
suggested a role for β-catenin signalling in chronic
liver injury, including driving HPC proliferation and
differentiation [30–34]. By contrast, Wnt/β-catenin
signalling in fibroblasts was reported to be pro-fibrotic
in systemic sclerosis, skin, lung, liver and kidney
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disease [35–38]. The cellular source and type of Wnt
proteins expressed in response to injury and their tar-
get cells may determine whether tissue regeneration or
fibrosis occurs. Macrophage- but not epithelial-derived
Wnts contributed to liver regeneration after partial
hepatectomy [39]; however, the role of macrophage-
derived Wnts in chronic liver disease, in particular in
the HPC niche, is unknown. In the current study, we in-
vestigated the contribution of macrophage-derived
Wnts to HPC activation and fibrogenesis during chronic
liver disease. To do so, we examined the phenotype of
mice with myeloid-targeted deletion of Wntless (Wls), en-
coding the chaperone Wls required for Wnt secretion
[40]. Mice with Wls-deficient macrophages exhibited en-
hanced ductular reactions and fibrosis in two murine
models of chronic liver disease. Our data are consistent
with roles for macrophage-derived Wnts in HPC matur-
ation and matrix remodelling to restrain net collagen de-
position during chronic liver disease progression.
Results
Myeloid-specific Wls knockout does not affect liver
macrophage abundance or localisation
To investigate the contribution of macrophage-derived
Wnt proteins to inflammation, HPC activation and fi-
brosis, we generated mice deficient in Wls expression
in myeloid cells by crossing Wls-loxp mice [40] with
LysM-Cre mice [41] for 4–10 generations. Wls knock-
out in macrophages was confirmed by qPCR for Wls in
bone marrow-derived macrophages (Additional file 1:
Figure S1A). LysM-Wls (Cre+) mice and littermate con-
trols (Cre-) were administered thioacetamide (TAA,
300 mg/L) in drinking water for 12 weeks as a model of
chronic liver injury. Reduced Wls expression in F4/80+
liver cells sorted by flow cytometry was confirmed by
qPCR (Additional file 1: Figure S1B–E). By contrast, Wls
expression in Epcam+ cells, sorted by flow cytometry, was
comparable between untreated Cre+ and Cre− animals,
confirming the specificity of targeting (Additional file 1:
Figure S1F). Consistent with a recent report [39], LysM-
Wls mice were viable and livers were histologically
normal. Wls deficiency did not affect the number or local-
isation of liver macrophages in control or TAA-treated
mice, as assessed by immunohistochemistry and image
analysis for F4/80 and qPCR for Emr1 (encoding the F4/
80 antigen) in whole liver (Fig. 1). To determine which
Wnt proteins are expressed by liver macrophages, we con-
ducted a PCR for a panel of Wnt ligands. Wnt3a, Wnt5a,
Wnt7a, Wnt7b and Wnt1 mRNAs were below the limit of
detection in F480+ cells from control or TAA-treated
mice; however, Wnt4 and Wnt6 were robustly detected
but not significantly altered by TAA treatment or
genotype (Additional file 1: Figure S1G–H).
Reduction in Wnt/β-catenin signalling during liver injury
in mice with Wls-deficient macrophages
In healthy livers, β-catenin localised to hepatocyte mem-
branes and bile duct epithelia, whereas after 12 weeks
TAA treatment, β-catenin stained hepatocyte membranes
and some nuclei, as well as HPC, in both LysM-Wls mice
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Fig. 1 LysM-Wls depletion does not affect macrophage abundance and localisation. F4/80+ liver macrophage localisation (representative stain, 5× original
magnification) (a). Quantification of F4/80+ staining (b) and whole liver Emr1 (encoding the F4/80 antigen) expression (c) in control and LysM-Wls mice
treated with water or TAA for 12 weeks. Data represent mean + SEM from 5 to 12 mice from 4 independent experiments. n.s. non-significant
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and littermate controls (Fig. 2a). Whilst no clear difference
in β-catenin expression or localisation in injured mice was
discernible, expression of the Wnt/β-catenin target gene,
Axin2, was elevated in livers from TAA-treated control
mice but not LysM-Wls mice (Fig. 2b), consistent with a
reduction in Wnt/β-catenin signalling in LysM-Wls mice
during liver injury. Whole liver expression of the Wnt/β-
catenin target genes Ccnd2 and Numb, which has previ-
ously been suggested to contribute to HPC hepatocellular
fate determination [14], was not significantly different be-
tween genotypes, although there was a trend towards re-
duced Numb expression in LysM-Wls mice (Fig. 2c and
data not shown).
Wls depletion in macrophages exacerbates TAA-induced
hepatic progenitor cell activation and fibrosis
After 12 weeks of TAA treatment, LysM-Wls mice exhib-
ited increased HPC activation, frequently associated with
mature ductular reactions, which were not observed in lit-
termate controls (pan-keratin staining, Fig. 3a, b). This
was associated with increased fibrosis (Picro-Sirius red
staining, Fig. 3c–e). Female mice were used in this study
because we observed that TAA-induced HPC activation
and fibrosis were more severe in females than males, how-
ever Wls deficiency in macrophages similarly exacerbated
the DR and fibrosis in male mice (Additional file 2:
Figure S2). The increased DR and fibrosis was not ex-
plained by increased susceptibility to TAA-induced injury,
as liver injury was comparable in LysM-Wls mice and litter-
mate controls, as assessed by serum ALTand liver histology
(Fig. 4a–c). The expression of the key pro-inflammatory cy-
tokines Tnf and Il6 that are produced by macrophages and
other cell types in response to liver injury and play critical
roles in liver inflammation, fibrosis and HPC activation
[20, 22, 42] was not significantly different between
LysM-Wls and littermate controls (data not shown).
Despite the increase in fibrosis in LysM-Wls mice,
mRNA levels of the key interstitial collagens contributing
to liver fibrosis [43], Col1a1, Col1a2 and Col3a1, were
comparable between LysM-Wls and littermate controls
(Fig. 5a–c). Although mRNA expression of Sma, which
encodes smooth muscle actin, was comparable between
genotypes (data not shown), there was a trend towards in-
creased Sma protein expression in LysM-Wls mice
(Fig. 5d, e), suggesting an increase in myofibroblast activa-
tion in these mice. Nevertheless, mRNA expression of the
pro-fibrogenic cytokines Tgfb and Ctgf [44] that play key
roles in myofibroblast activation did not differ between ge-
notypes (Fig. 5f, g).
Hepatic progenitor cells express an immature profile in
mice with Wls-deficient macrophages
Paralleling the ductular reaction, Epcam (Tacstd1) liver
mRNA levels were elevated in LysM-Wls mice compared
to littermate controls (Fig. 6a), whereas the expression of
the biliary keratin, Krt19, did not differ. Epcam is a cell
surface glycoprotein expressed on tissue stem cells with
regenerative capacity and is normally downregulated upon
terminal differentiation [45]. To investigate the effects of
macrophage-derived Wnts on HPC gene expression, we
sorted Epcam+ cells from the liver non-parenchymal frac-
tion to enrich for HPC. Expression of Epcam itself was
increased in Epcam+ cells from TAA-treated LysM-Wls
mice compared to littermate controls (Fig. 6b). Trop2
(Tacstd2), which encodes an Epcam-related protein re-
ported to be specifically induced in HPC upon liver in-
jury [46], was elevated in TAA-treated control mice and
hyper-induced in LysM-Wls mice (Fig. 6c). We investigated
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Fig. 2 Reduced Wls expression in macrophages from LysM-Wls mice is associated with reduced β-catenin target gene expression. a β-Catenin staining
(representative, 10× original magnification) and whole liver expression of b Axin2 and c Numb in control and LysM-Wls mice treated with
water or TAA for 12 weeks. Data represent mean+/−SEM of 5–12 mice from 4 independent experiments
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the expression of the Notch target gene Hey1 and the Wnt/
β-catenin target genes Axin2 and Numb in Epcam+ cells,
as the Notch and Wnt/β-catenin pathways have previously
been suggested to have opposing roles in determining
HPC fate [14, 17], to provide evidence for direct effect
of macrophage-derived Wnts on HPC, however these
genes were only marginally detected in sorted cells (data
not shown).
Macrophage metalloproteinase expression is reduced in
TAA-treated LysM-Wls mice
Macrophage production of the HPC mitogen, Tweak, has
been implicated in driving HPC proliferation [15, 24]. Al-
though TAA inducible, Tweak expression did not differ in
whole liver or flow cytometry-sorted F4/80+ cells from
control and LysM-Wls mice (Fig. 7a, b). As in whole liver,
expression of the pro-inflammatory cytokines, Il6 and Tnf,
and the pro-fibrotic cytokine, Tgfb, did not differ between
LysM-Wls and control macrophages (data not shown).
Since macrophages play a key role in matrix remodelling,
we also examined the expression of key matrix remodel-
ling factors implicated in liver fibrosis and repair [47]. We
found myeloid deletion of Wls impaired injury-mediated
upregulation of Mmp13 (encoding the key interstitial col-
lagenase in rodents, Mmp13) and Mmp12 (encoding the
elastase Mmp12) mRNAs in whole liver and purified F4/
80+ cells (Fig. 7c–f ). Mmp2 and Mmp8 were induced in
TAA-injured livers but not differentially expressed in Wls-
deficient and control mice, whereas no alteration in liver
or macrophage Mmp9 expression was observed (data not
shown). Furthermore, in TAA-treated LysM-Wls mice,
the expression of Timp1, encoding the key Mmp inhibitor
Timp1 that blocks interstitial collagen degradation [1],
was higher compared to littermate controls (Fig. 7g).
These data are consistent with the hypothesis that fibroly-
sis, as well as fibrogenesis, is dynamically regulated during
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Fig. 3 Increased ductular reaction and fibrosis in LysM-Wls mice. a Representative CKWSS staining and b ductular reaction grade in livers from 12-week
water- and TAA-treated control and LysM-Wls mice. c Representative Picro-Sirius Red staining, d fibrosis score and e collagen proportionate area in livers
from water- and 12-week TAA-treated control and LysM-Wls mice. Data represent mean + SEM of 8–17 mice from 4 independent experiments
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TAA-mediated liver injury and suggest that macrophage-
derived Wnt proteins promote matrix remodelling, via
Mmp13 and Mmp12, potentially restraining fibrosis.
Wls depletion in macrophages exacerbates CDE-induced
hepatic progenitor cell activation and fibrosis
To determine whether macrophage-derived Wnts con-
tribute to the regulation of HPC activation and fibrogen-
esis in multiple contexts of liver injury, we employed an
alternative model of liver injury and fibrosis. The choline-
deficient ethionine-supplemented (CDE) diet induces a ro-
bust DR but a different pattern of fibrosis to TAA [48].
Liver injury and fibrosis were also more severe in female
mice than male mice in this model (data not shown). Simi-
lar to the TAA model, HPC activation and fibrosis were ex-
acerbated in CDE-treated LysM-Wls mice compared to
littermate controls, in the absence of alterations in whole
liver Col1a1, Col1a2, Col3a1, Sma and Il6 expression be-
tween LysM-Wls mice and littermate controls (Additional
file 3: Figure S3A–E and data not shown). Epcam ex-
pression was elevated in CDE-treated LysM-Wls mice,
in whole liver and Epcam+ cells (Additional file 3:
Figure S3F, G), suggesting similar alterations in HPC
phenotype in both models. As in the TAA model,
Timp1 mRNA expression was increased in CDE-
treated LysM-Wls mice compared to littermate con-
trols (Additional file 3: Figure S3I); however, Mmp13
was not detectable in the majority of CDE-treated
mice and there was no difference in Mmp12, Mmp8,
Mmp2 or Mmp9 expression (data not shown). Wnt4
and Wnt6 were expressed in macrophages from CDE-
treated mice, regardless of genotype (data not shown).
Discussion
Macrophages contribute to the dynamic interplay be-
tween liver inflammation, fibrosis and regeneration via
multiple mechanisms, at different locations and differ-
ent disease stages. Inflammatory, bone marrow-derived
monocytes infiltrate the liver in response to injury, where
they are dynamically reprogrammed, depending on the na-
ture and chronicity of the injury [10, 49–52]. Macrophages
are among the earliest responders to liver injury, having
roles in phagocytosis of apoptotic and necrotic cells and
releasing soluble mediators, such as TNF and IL-6, that
orchestrate inflammatory and ultimately pro-fibrogenic re-
sponses to chronic injury. Macrophages are also promi-
nent components of the hepatic progenitor cell niche,
which is closely associated with liver fibrogenesis [2, 8, 9]
and repair; although the fate relationships among hepato-
cytes, cholangiocytes and HPC and the contribution of
HPC to liver fibrosis and regeneration are controversial
[5–7, 53–55]; and the factors determining their activa-
tion and differentiation are not well understood. Wnt
proteins, potentially derived from macrophages, have
been suggested to promote liver regeneration by driving
HPC hepatocellular differentiation [14, 17, 32], which
could theoretically ameliorate liver fibrosis by promot-
ing regeneration. Wnt proteins, however, constitute a
large family of proteins that have been variously attrib-
uted pro- and anti-fibrogenic properties [35–38] and
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Fig. 4 Comparable injury and inflammation in LysM-Wls and control mice. a Serum ALT levels in water- and 12-week TAA-treated control and
LysM-Wls mice. Data represent mean+/−SEM of 8–10 mice from 2 independent experiments. b Lobular inflammation score and c representative
H&E staining, in water- and 12-week TAA-treated control and LysM-Wls mice. Data represent mean + SEM of 8–17 mice from 4 experiments
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which likely have multiple potential target cells and
mechanisms of action during chronic liver disease. We
investigated the role of macrophage-derived Wnt pro-
teins in fibrogenesis in two models of chronic liver dis-
ease and demonstrate that ablating Wls expression in
myeloid cells exacerbated HPC activation and fibrosis.
Although the role of β-catenin in liver homeostasis
and injury has been extensively studied [18], the contri-
bution and sources of specific β-catenin-dependent Wnt
proteins are little studied, and β-catenin-independent
Wnt signalling is even less studied [27, 32, 39]. β-catenin
is essential for hepatocyte-mediated liver regeneration
after partial hepatectomy, and it was recently shown that
macrophage- but not epithelium-derived Wnt proteins
contribute to β-catenin activation in this setting [39]. A
novel, β-catenin-dependent population of self-renewing
hepatocytes maintained by endothelial-derived Wnts was
also recently identified, although the role of these cells
in liver injury has not yet been investigated [56]. In
humans with acute liver failure, nuclear β-catenin local-
isation in hepatocytes correlated with patient survival
and reduced requirement for liver transplant [29], con-
sistent with a pro-regenerative role for β-catenin, al-
though Wnt proteins were not directly implicated in this
study. Interestingly, β-catenin depletion from mature he-
patocytes in healthy mice caused HPC expansion, and
hepatocytes were gradually replaced by β-catenin-positive
HPC [57]. β-catenin has also been implicated in HPC-
mediated liver regeneration in murine chronic liver dis-
ease [30, 33], and hepatocyte-derived Wnt1 promoted
HPC differentiation in rats, following partial hepatectomy
and 2-acetylaminofluorene (AAF) treatment [32]. Our
data demonstrating increased fibrosis and associated with
more extensive ductular reactions and a more cholangio-
cytic HPC phenotype (increased Epcam and Trop2 ex-
pression) in LysM-Wls mice are consistent with a role for
Wnt proteins in protecting from fibrosis by promoting
HPC hepatocellular differentiation. However, we did not
observe any difference in β-catenin localisation in livers
from LysM-Wls and control mice. Whilst the β-catenin
target gene Axin2 was reduced in whole liver in LysM-
Wls mice, it was below the limit of detection in Epcam+
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Fig. 5 Comparable myofibroblast activation in LysM-Wls and control mice. Whole liver expression of a Col1a1, b Col1a2 and c Col3a1 in
water- and 12-week TAA-treated control and LysM-Wls mice. d Representative SMA staining and e quantification of SMA staining (mean + SEM, n= 5 per
group) in livers from water- and 12-week TAA-treated control and LysM-Wls mice. Whole liver expression of f Ctgf and g Tgfb in water- and
12-week TAA-treated control and LysM-Wls mice. Data represent mean + SEM of 8–17 mice from 4 independent experiments. n.s. not significant
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cells (which include HPC), so we could not ascertain
whether this pathway was differentially activated in these
cells in the absence of macrophage-derived Wnts. It is
possible that cells with activated β-catenin signalling are
not represented among the sorted population due to
maturation-associated Epcam downregulation [45]. Al-
ternatively, rather than representing a block in hepato-
cellular differentiation, the expanded DR observed in
LysM-Wls mice could result from a pro-proliferative
drive, via the activation of Hedgehog or other growth
factors [58, 59], the persistence of collagen or altered
matrix composition [11], or from hepatocyte metapla-
sia, rather than HPC activation [54].
In addition to their potential direct (or indirect) effects
on HPC, macrophage-derived Wnts could influence HPC
activation and fibrosis via additional target cells and mecha-
nisms. Wnt/β-Catenin signalling, for example, has been im-
plicated in promoting stellate cell quiescence [60]; but we
did not observe any difference in SMA expression or key
cytokine regulators of myofibroblast activation, in LysM-
Wls and control mice. In both the TAA and CDE models,
increased hepatic collagen deposition in LysM-Wls mice
occurred in the absence of increased expression of the key
interstitial collagens, Col1a1, Col2a1 and Col3a1. In con-
trast to a typical pro-fibrogenic signature, with evidence of
increased myofibroblast activation and collagen production,
Timp1 mRNA, encoding a key hepatic Mmp inhibitor that
prevents remodelling of the fibrotic scar [61, 62], was in-
creased in LysM-Wls mice compared to littermate controls
in both the TAA and CDE models. Moreover, in the TAA
model, macrophage Mmp13 and Mmp12 expression was
reduced in LysM-Wls mice. These data suggest the hypoth-
esis that macrophage-derived Wnts promote fibrolysis,
which dynamically counter-balances collagen accumulation,
even during active fibrogenesis. The contribution of matrix
remodelling to fibrogenesis during ongoing liver injury is
not well understood, but studies altering the Timp to Mmp
balance have consistently confirmed the potent influence of
this ratio on the development and resolution of liver fibro-
sis [1]. Macrophages clearly play an essential role in the
resolution of established fibrosis, after cessation of liver in-
jury [10, 51, 52]. This involves reprogramming recruited
monocytes/macrophages to a pro-resolution phenotype, in-
cluding increased phagocytic activity and increased Mmp12
and Mmp13 expression, in conjunction with loss of liver
Timp1 mRNA and protein expression [52]. Interestingly,
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Fig. 6 Increased Epcam expression in Epcam+ cells from LysM-Wls
mice. a Whole liver expression of Epcam in water- and 12-week
TAA-treated control and LysM-Wls mice (mean + SEM of 8–17
mice from 4 independent experiments). Expression of b Epcam
and c Trop2 in flow cytometry-sorted Epcam+ cells (pooled from
3 to 6 mice) from water- and 12-week TAA-treated control and
LysM-Wls mice (mean + range of 2 independent experiments)
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administration of bone marrow-derived macrophages dur-
ing ongoing toxic injury was sufficient to ameliorate fi-
brosis, and this was associated with increased Mmp13
expression [13]. Similarly, Barnes and colleagues re-
cently reported a reduced rate of collagen degradation,
associated with reduced recruitment of macrophages to
the fibrotic scar, and reduced Mmp13 activity during
CCL4-induced liver injury in mice lacking the chemokine
MIF [63]. Mmp and Timp functions are not, however, lim-
ited to matrix proteolysis. Timp1 inhibits myofibroblast
apoptosis [64], for example, whilst Mmp13 could con-
tribute to fibrosis resolution via activation of latent hepato-
cyte growth factor and multiple downstream mechanisms
[65–69]. Investigating the dynamic remodelling of multiple
matrix components during chronic injury will be import-
ant to determine the functional relevance of the Timp1/
Mmp balance in different models at different stages of dis-
ease progression.
Conclusions
We have shown for the first time that the net effect of
myeloid-derived Wnt proteins in chronic liver disease
is to dampen HPC activation and fibrogenesis. Multiple
Wnt proteins acting on different target cells may con-
tribute to this phenotype, including direct effects on
HPC fate, collagen-producing myofibroblasts and mac-
rophages. Whilst Wnt induction, particularly leading to
β-catenin activation, is not a viable therapeutic strategy
in the setting of chronic liver disease, due to the risk of
cancer development [70]; elucidation of the downstream
pathways mediating Wnt proteins’ anti-fibrogenic effects
may reveal novel, specific therapeutic targets. Most signifi-
cantly, however, these data suggest that pro- and anti-
fibrogenic macrophage functions co-exist during disease
progression and support the notion that reprogramming
macrophages or otherwise enhancing anti-fibrogenic path-
ways may be a viable therapeutic strategy to ameliorate
fibrogenesis during chronic liver disease.
Methods
Transgenic mice and in vivo models
All animal experiments were performed with approval
from the University of Queensland Animal Ethics Com-
mittee (MED/PAH/156/13/PAHRF/NHMRC, UQDI/571/
12/NHMRC/AIDRCC). To conditionally delete Wls from
macrophages, homozygous Wlsflox/flox mice [40] were
crossed with LysM-Cre transgenic mice [41] for 4–10 gen-
erations. Offspring with the genotype Wlsflox/flox; LysM-
Cre-positive represents Wls macrophage knockouts, whilst
Wlsflox/flox; LysM-Cre-negative was used as controls. Six to
9-week-old mice were administered with 30 mg/L thioace-
tamide (TAA, Sigma) in drinking water for 12 weeks [71]
or a modified choline-deficient ethionine-supplemented
(CDE) diet for 6 weeks [48], to induce chronic liver in-
jury and fibrosis. The modified CDE diet was optimised
by Professor George Yeoh [48] (UWA, Australia) and
was custom made by MP Biosciences (Santa Ana, USA).
The diet consisted of 70 % choline-deficient diet
(Cat#0296021410) and 30 % control (choline-suffi-
cient) diet (Cat#0296041210). At the end of the treat-
ment period, mice were euthanised and a blood sample
taken for serum isolation. Livers were perfused with
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Fig. 7 Reduced macrophage matrix metalloproteinase expression
in LysM-Wls mice. Tweak expression in a whole liver and b flow
cytometry-sorted macrophages. Mmp13 expression in c whole liver
and d flow cytometry-sorted macrophages, Mmp12 expression in e
whole liver and f flow cytometry-sorted macrophages and g whole
liver expression of Timp1 in water- and 12-week TAA-treated control and
LysM-Wls mice. Data represent mean + SEM of 8–17 mice (whole liver)
or mean + range of 2 independent experiments (sorted macrophages
pooled from 3 to 6 mice in each experiment)
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10 ml of PBS via the portal vein in situ prior to tissue
harvest to minimise blood contamination. Portions of
the liver were fixed in 10 % neutral buffered formalin
and embedded in paraffin or homogenised in TRI re-
agent and stored at −80 °C for RNA isolation. The re-
mainder of the liver was used to isolate non-parenchymal
cells. Serum ALT levels were measured using the MaxDis-
covery Alanine Transaminase Color Endpoint Assay (Bioo
Scientific, Austin, TX, USA).
Non-parenchymal cell isolation
Non-parenchymal cells were isolated by finely dissociat-
ing the liver tissue using surgical scissors then passing
the fragments through a stainless steel strainer with the
addition of 14 ml of Hank’s Based Salt Solution (HBSS)
containing 1 mg/ml type 4 collagenase (Worthington Bio-
chemical corporation, Lakewood, NJ, USA) 1 μg/ml DNase
I (Sigma), 100 U/ml penicillin and 100 μg/ml streptomycin.
The cell suspension was filtered through a 70-μM filter
(Becton Dickinson) and incubated at 37 °C for 5 min, prior
to the addition of 10 mM EDTA and a further 5-min incu-
bation period. The lysate was washed twice in cold PBS
containing 2 % FBS (FACS buffer) and resuspended in
25 ml of 33 % Percoll in PBS (isotonic) and centrifuged at
600 × g for 15 min with no brake. The supernatant
was discarded and the pellet washed twice and resus-
pended in FACS buffer. Freshly isolated non-parenchymal
cells (~5 × 106) per liver were stained with anti-F4/80-PE
(clone BM8) and anti-Epcam-APC (clone G8.8) (Biole-
gend) antibodies for 30 min at room temperature, washed
twice and resuspended in FACS buffer for sorting. PE-
and APC-positive cells were sorted using an Astrios
Moflo, achieving >90 % purity. Sorted cells were resus-
pended in TRI reagent (Sigma) for RNA purification.
RNA purification and qPCR
RNA from whole liver (5 μg) or sorted cells (entire yield)
was transcribed to cDNA using oligodT priming and
Superscript III (Life Technologies). Quantitative real-time
PCR (qPCR) for genes of interest was performed using
SYBR green (ABI) on an HT9000 or VIA-VII cycler with
default cycle settings. Relative expression was determined
using Hprt as housekeeping gene and the delta-Ct method
and expressed as Target/Hprt. Primer sequences used in
this study were the following: Hprt-F: TGCTGGATTA
CATCAAAGCACTG, Hprt-R: CCCCTGTTGACTGGTC
ATTACAA; Ccnd1-F CACAACGCACTTTCTTTCCAGA
Ccnd1-R CTTGACTCCAGAAGGGCTTCAA Numb-F
CAATGAGTTGCCTTCCACTATGC Numb-R ATCTGG
GAACACAAGGAGCTGA Mmp12-F TACCCCAAGCT
GATTTCCACAC Mmp12-R GCTCCTTGGAAGATGT
AGTAGTGTCTTT Mmp13-F ACAAAGATTATCCCCG
CCTCAT Mmp13-R GGCCCATTGAAAAAGTAGA
TATAGCC Timp1-FAAGGGCTAAATTCATGGGTTCC
Timp1-R ACAGCCTTGAATCCTTTTAGCATC Mmp9-F
AGGGGCGTGTCTGGAGATTC Mmp9-R TCCAGGG
CACACCAGAGAAC Tweak-F CGCTCTTAGTCTGGTC
CTGGTTT Tweak-R CACCAGTCTCCTCTATGGGG
GTA Tgfb-F GTGGCTGAACCAAGGAGACG Tgfb-R
GGCTGATCCCGTTGATTTCC F480-F CTGTCTGC
TCAACCGTCAGGTA F480-R AGAAGTCTGGGAAT
GGGAGCTAA E Epcam-F CGGGGATTGTTGTCCTG
GTT Epcam-R GCACGGCTAGGCATTAAGCTC Trop2-
F AGGAGCTGGGGGAGATGAGA Trop2-R CCAACC
CATCTGGTCTGAGG Krt19-F CCTAGCCAAGATCCTG
AGTGAGAT Krt19-R TGGGTGTTCAGCTCCTCAATC
Ctgf-F GTCAAGCTGCCTGGGAAATG Ctgf-R AATGT
GTCTTCCAGTCGGTAGGC Il6-F GCTGGTGACAAC
CACGGCCT Il6R GGCATAACGCACTAGGTTTGCCG
Tnf-F AGGGGCCACCACGCTCTTCT Tnf-R CGGGG
CAGCCTTGTCCCTTG Wls-F CAAATCGTTGCCTTTC
TGGTG Wls-R TTGTCACACTTGTTAGGTCCC Wnt4-F
AAGAGGAGACGTGCGAGAAA Wnt4-R CACCACCT
TCCCAAAGACAG Wnt6-F TCAAGACTCTTTATGGA
TGCGC Wnt6-R ATGGCACTTACACTCGGTG Sma-F
GATCCTGACTGAGCGTGGCTAT Sma-R CGTGGCCA
TCTCATTTTCAAAG mMmp2-F TTGCAGGAGACAA
GTTCTGGAGATA mMmp2-R CACGACGGCATCCAG
GTTAT mMmp8-F GGTTACCCCAAAAGCATACCAA
mMmp8-R CACTGAAGAAGAGGAAGAAGGAGTC
mCol1a2-F CACCCCAGCGAAGAACTCATAC mCol1a2-
R CCCCTTCTACGTTGTATTCAAACTG mCol3a1-F
TGGGATCAAATGAAGGCGAAT mCol3a1-R GCTCCA
TTCCCCAGTGTGTTTAG.
Histology, immunohistochemistry and image analysis
H&E and Sirius red stains were performed and histological
changes (inflammatory infiltrate and fibrosis) were assessed
by two experienced hepatopathologists (GCM and ADC).
Fibrosis stage was assessed using a modified METAVIR
score as previously described [72]; briefly, stage 1: peri-
portal or centrilobular fibrosis, stage 2: some septa, stage
3: many septa, stage 4: cirrhosis. Deparaffinised liver tissue
sections were immunolabelled as described previously
[73]. Antibodies used in this study were cytokeratin wide-
spectrum screening (CKWSS, DAKO), F4/80 (Abcam),
SMA (1A4, DAKO), β-catenin (Cell Signalling). HPC acti-
vation/ductular reactions were graded from CKWSS-
stained sections according to the following schema: 1:
CKWSS+ cells surrounding <50 % of portal vein, 2:
CKWSS+ cells surrounding >50 % of portal vein; 3:
CKWSS+ cells forming septa covering <50 % distance be-
tween two structures, 4: CKWSS+ cells forming septa cov-
ering >50 % distance between two structures. SMA and
F4/80 image analysis were performed using ImageJ from
ten captured images per section, each representing an
area 310 × 250 μm in size. Sirius Red image analysis
was performed using the positive pixel count algorithm
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in Aperio ImageScope from Aperio AT slide scans, from an
area of 5–10 mm2 for each liver specimen. The algorithm
was optimised to detect red pixels (hue value 0, hue width
0.1 and colour saturation threshold 0.22). All portal tracts
and central veins greater than 100 μm in size were removed
as they contain a large amount of collagen and therefore
prevent quantification of fibrosis-associated collagen.
Statistical analysis
Group comparisons were performed using the Mann–
Whitney-U test. A two-tailed p value of 0.05 was con-
sidered statistically significant. All statistical analyses
were performed using Prism Version 6 (GraphPad).
Additional files
Additional file 1: Figure S1. Wls depletion and Wnt expression in
Wls-loxp × LysM-Cre mice. (A) RT-PCR quantification of Wls expression in
bone marrow-derived macrophages from Wlsfl/fl and LysM-Cre+/− mice
(n = 4–5, Mann–Whitney-U test). (B) Flow cytometry gating strategy for
sorting F4/80+ and Epcam+ cells from liver non-parenchymal cells. Post-sort
analysis of (C) F4/80+ and (D) Epcam+ cells. RT-PCR quantification of Wls
expression in sorted (E) F4/80+ and (F) Epcam+ cells from control and
12-week TAA-treated mice. RT-PCR quantification of (G) Wnt4 and (H)
Wnt6 expression in sorted F4/80+ cells from control and 12-week TAA-treated
mice. Sorted cells were pooled from 3 to 6 mice from control and LysM-Wls
mice. Data represent mean + range of 2 independent experiments.
(EPS 1589 kb)
Additional file 2: Figure S2. Increased ductular reaction and fibrosis in
male LysM-Wls mice compared to littermate controls. (A) Ductular reaction
grade, (B) fibrosis score and (C) whole liver Col1a1 expression in livers from
water- and 12-week TAA-treated control and LysM-Wls male mice. Data
represent mean + SEM of 4–8 mice from 3 independent experiments.
(EPS 478 kb)
Additional file 3: Figure S3. Increased ductular reaction and fibrosis in
LysM-Wls mice in the CDE model of chronic liver disease. Ductular reaction
grade (A), fibrosis score (B) and whole liver expression of Col1a1 (D), Col3a1 (E),
Sma (F), Epcam (G) and Timp1 (I) in livers from LysM-Wls and control mice fed
with a CDE diet for 6 weeks. Data represent mean + SEM from n= 3 mice
from 1 experiment, representative of 3 independent experiments. (H) Epcam
expression in flow cytometry-sorted Epcam+ cells (pooled from 3 mice) from
LysM-Wls and control mice treated fed with a CDE diet for 6 weeks.
Data represent mean + range of PCR duplicates, representative of 3
independent experiments. (EPS 509 kb)
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